格林國際控股(02700.HK)執行董事兼主席俞淇綱出售2.47億股公司股份
格隆匯12月28日丨格林國際控股(02700.HK)公吿,公司董事會收到金福國際投資有限公司的通知,於2020年12月29日,金福與三位受讓人訂立及完成股份出售協議,按每股0.06港元的代價絕對轉讓和歸屬其在2.47億股公司股份的權益予受讓人。
金福是俞淇綱先生(公司執行董事兼主席)的受控法團及聯繫人。股份出售後,金福不再擁有公司股份權益,但暢健有限公司(由俞先生最終及全資擁有的受控公司)和偉信國際有限公司(由俞先生的配偶全資擁有,因此亦視為俞先生之聯繫人)繼續擁有合計18.5億股股份,約佔公司已發行股份的56.08%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.